Workshop- and Telephone-Based Interventions to Improve Adverse Drug Reaction Reporting A Cluster-Randomized Trial in Portugal

被引:0
作者
Herdeiro, Maria Teresa [1 ,2 ,3 ,4 ]
Ribeiro-Vaz, Ines [2 ]
Ferreira, Monica [4 ]
Polonia, Jorge
Falcao, Amilcar [5 ,6 ]
Figueiras, Adolfo [7 ,8 ]
机构
[1] Univ Porto, Fac Med, Unidade Farmacovigilancia Norte, No Pharmacovigilance Ctr, P-4200319 Oporto, Portugal
[2] Ctr Invest Tecnol & Sistemas Informacao Saude CIN, Ctr Hlth Technol & Informat Syst Res, Oporto, Portugal
[3] IPSN CESPU, Hlth Technol Res Ctr, Ctr Invest Tecnol Saude CITS, Gandra, Portugal
[4] Univ Aveiro, Ctr Cell Biol, P-3800 Aveiro, Portugal
[5] Univ Coimbra, Ctr Neurosci & Cell Biol, CNC, Coimbra, Portugal
[6] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[7] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain
[8] CIBER Epidemiol & Salud Publ CIBERESP, Consortium Biomed Res Epidemiol & Publ Hlth, Barcelona, Spain
关键词
CONTINUING MEDICAL-EDUCATION; PRESCRIPTION; PHYSICIANS; ATTITUDES; SAFETY; CARE;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Spontaneous reporting of adverse drug reactions (ADRs) is the method most widely used by pharmacovigilance systems, with the principal limitation being the physician's underreporting. Objective: This study sought to evaluate the results of workshop and telephone-interview interventions designed to improve the quantity and relevance of ADR reporting by physicians. Methods: A cluster-randomized controlled trial was conducted on 6579 physicians in northern Portugal in 2008. Following randomization, we allocated 1034 physicians to a telephone-interview intervention, 438 to a workshop intervention and the remaining 5107 to the control group. At the workshop, a real clinical case was presented and participants were then asked to report on it by completing the relevant form. In the telephone intervention, participants were asked (i) whether they had ever had any suspicion of ADRs; (ii) whether they had experienced any difficulties in reporting; (iii) whether they remembered the different methods that could be used for reporting purposes; and (iv) whether they attached importance to the individual physician's role in reporting. We followed up physicians to assess ADR reporting rates to the Northern Pharmacovigilance Centre. In terms of relevance, adverse reactions were classified as serious or unexpected. Statistical analysis was performed on an intention-to-treat basis, and generalized linear mixed models were applied using the penalized quasi-likelihood method. The physicians studied were followed up over a period of 20 months. Results: Two hundred physicians underwent the educational intervention. Comparison with the control group showed that the workshop intervention increased the spontaneous ADR reporting rate by an average of 4-fold (relative risk [RR] 3.97; 95% CI 3.86, 4.08; p<0.001) across the 20 months post-intervention. Telephone interviews, in contrast, proved less efficient since they led to no significant difference (p = 0.052) vis-a-vis the control group in ADR reporting (RR 1.02; 95% CI 1.00, 1.04). The effects of the interventions on the reporting rate of serious and high-causality ADRs indicated that the RRs associated with workshops were 6.84 (95% CI 6.69, 6.98; p < 0.001) for serious ADRs and 3.58 (95% CI 3.51, 3.66; p<0.001) for high-causality ADRs. Conclusions: Whereas telephone interventions only increased spontaneous reporting in the first 4 months of follow-up, workshops significantly increased both the quantity and relevance of spontaneous ADR reporting for more than 1 year.
引用
收藏
页码:655 / 665
页数:11
相关论文
共 30 条
  • [21] Reporting of adverse drug reactions by hospital doctors and the response to intervention
    McGettigan, P
    Golden, J
    Conroy, RM
    Arthur, N
    Feely, J
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 44 (01) : 98 - 100
  • [22] Educational outreach visits: effects on professional practice and health care outcomes
    O'Brien, M. A.
    Rogers, S.
    Jamtvedt, G.
    Oxman, A. D.
    Odgaard-Jensen, J.
    Kristoffersen, D. T.
    Forsetlund, L.
    Bainbridge, D.
    Freemantle, N.
    Davis, D. A.
    Haynes, R. B.
    Harvey, E. L.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (04):
  • [23] An Intervention to Improve Spontaneous Adverse Drug Reaction Reporting by Hospital Physicians A Time Series Analysis in Spain
    Pedros, Consuelo
    Vallano, Antoni
    Cereza, Gloria
    Mendoza-Aran, Gemma
    Agusti, Antonia
    Aguilera, Cristina
    Danes, Immaculada
    Vidal, Xavier
    Arnau, Josep M.
    [J]. DRUG SAFETY, 2009, 32 (01) : 77 - 83
  • [24] Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
    Pirmohamed, M
    James, S
    Meakin, S
    Green, C
    Scott, AK
    Walley, TJ
    Farrar, K
    Park, BK
    Breckenridge, AM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456): : 15 - 19
  • [25] Strategies to increase the sensitivity of pharmacovigilance in Portugal
    Ribeiro-Vaz, Ines
    Herdeiro, Maria Teresa
    Polonia, Jorge
    Figueiras, Adolfo
    [J]. REVISTA DE SAUDE PUBLICA, 2011, 45 (01): : 129 - 135
  • [26] PHYSICIAN REPORTING OF ADVERSE DRUG-REACTIONS - RESULTS OF THE RHODE-ISLAND ADVERSE DRUG REACTION REPORTING PROJECT
    SCOTT, HD
    THACHERRENSHAW, A
    ROSENBAUM, SE
    WATERS, WJ
    GREEN, M
    ANDREWS, LG
    FAICH, GA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (13): : 1785 - 1788
  • [27] Morning report: A forum for reporting adverse drug reactions
    Sivaram, CA
    Johnson, S
    Tirmizi, SN
    Robertson, V
    Garcia, D
    Sorrells, E
    [J]. JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT, 1996, 22 (04): : 259 - 263
  • [28] Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines
    Smith, CC
    Bennett, PM
    Pearce, HM
    Harrison, PI
    Reynolds, DJM
    Aronson, JK
    GrahameSmith, DG
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (04) : 423 - 429
  • [29] SYSTEM FOR VOLUNTARY REPORTING OF ADVERSE DRUG-REACTIONS IN A UNIVERSITY HOSPITAL
    VORCEWEST, TE
    BARSTOW, L
    BUTCHER, B
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (11): : 2300 - 2303
  • [30] World Health Organization The Uppsala Monitoring Centre, GLOSS TERMS US PHARM